FIELD: biotechnology
SUBSTANCE: group of inventions relates to the field of biotechnology, namely to the preparation of the ribonucleoprotein complex CRISPR / Cas and the method for its production. The inventions can be used to identify the genome of the SARS-CoV-2 virus.
EFFECT: inventions ensure the detection of single copies of the SARS-CoV-2 virus RNA.
6 cl, 16 dwg, 5 tbl, 5ex
| Title | Year | Author | Number | 
|---|---|---|---|
| CRISPR-CAS14 SYSTEM FOR DETECTING SARS-CoV-2 VIRUS RNA AT ULTRA-LOW CONCENTRATIONS | 2021 | 
 | RU2764020C1 | 
| METHOD FOR DETECTING SARS-CoV-2 VIRUS RNA AT ULTRA-LOW CONCENTRATIONS AND SPECIFIC OLIGONUCLEOTIDES FOR USE IN THE METHOD | 2021 | 
 | RU2764022C1 | 
| METHOD FOR OBTAINING A PREPARATION OF THE CRISPR/Cas 12 RIBONUCLEOPROTEIN COMPLEX AND PREPARATION FOR DETECTING SARS-CoV-2 VIRUS RNA IN ULTRA-LOW CONCENTRATIONS | 2021 | 
 | RU2764015C1 | 
| METHOD FOR DETECTING SARS-CoV-2 VIRUS RNA IN ULTRA-LOW CONCENTRATIONS AND SPECIFIC OLIGONUCLEOTIDES FOR USE IN THE METHOD | 2021 | 
 | RU2764021C1 | 
| CRISPR-Cas 12 SYSTEM FOR DETECTING SARS-CoV-2 VIRUS RNA IN ULTRA-LOW CONCENTRATIONS | 2021 | 
 | RU2764023C1 | 
| METHOD OF OBTAINING A PREPARATION OF THE RIBONUCLEOPROTEIN COMPLEX CRISPR-CAS12 AND A PREPARATION FOR DETECTING HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) RNA IN ULTRA-LOW CONCENTRATIONS | 2022 | 
 | RU2802781C1 | 
| METHOD OF DETECTION OF RNA OF HEPATITIS C VIRUS GENOTYPES 1B AND 3A IN ULTRA-LOW CONCENTRATIONS AND SPECIFIC OLIGONUCLEOTIDES FOR USE IN THE METHOD | 2022 | 
 | RU2802079C1 | 
| CRISPR-CAS12 SYSTEM FOR DETECTING HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) RNA IN ULTRA-LOW CONCENTRATIONS IN ULTRA-LOW CONCENTRATIONS | 2022 | 
 | RU2802783C1 | 
| METHOD OF PRODUCING A PREPARATION OF A RIBONUCLEOPROTEIN COMPLEX CRISPR-CAS AND A PREPARATION FOR DETECTING HEPATITIS C VIRUS RNA OF GENOTYPES 1B AND 3A IN ULTRA-LOW CONCENTRATIONS | 2022 | 
 | RU2799430C1 | 
| METHOD FOR PRODUCING AN AGENT OF THE RIBONUCLEOPROTEIN COMPLEX CRISPR-Cas12 AND AGENT FOR DETECTING THE DNA OF THE HEPATITIS B VIRUS IN ULTRA-LOW CONCENTRATIONS | 2021 | 
 | RU2792891C1 | 
Authors
Dates
2022-01-12—Published
2021-09-30—Filed